NYSE: BG
Bunge
Consumer Staples · Fats & Oils
52-week range
Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$20.5B
Show tableHide table
| Period | Market cap |
|---|---|
| FY2021, ended Dec 31, 2021 | $14.2B |
| FY2022, ended Dec 31, 2022 | $15.3B |
| FY2023, ended Dec 31, 2023 | $14.5B |
| FY2024, ended Dec 31, 2024 | $10.4B |
| FY2025, ended Dec 31, 2025 | $17.2B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $20.5B |
Revenue
By fiscal year, then the trailing 12 months.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$93.5B
Show tableHide table
| Period | Revenue |
|---|---|
| FY2021, ended Dec 31, 2021 | $59.2B |
| FY2022, ended Dec 31, 2022 | $67.2B |
| FY2023, ended Dec 31, 2023 | $59.5B |
| FY2024, ended Dec 31, 2024 | $53.1B |
| FY2025, ended Dec 31, 2025 | $70.3B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $93.5B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2021, ended Dec 31, 2021 | $2.08B | −$3.29B |
| FY2022, ended Dec 31, 2022 | $1.61B | −$6.10B |
| FY2023, ended Dec 31, 2023 | $2.24B | $2.19B |
| FY2024, ended Dec 31, 2024 | $1.14B | $524M |
| FY2025, ended Dec 31, 2025 | $816M | −$879M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.16B | −$2.66B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$524M
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2021, ended Dec 31, 2021 | $902M |
| FY2022, ended Dec 31, 2022 | $1.10B |
| FY2023, ended Dec 31, 2023 | $2.60B |
| FY2024, ended Dec 31, 2024 | $3.31B |
| FY2025, ended Dec 31, 2025 | $1.14B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $524M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$16.7B
Show tableHide table
| Period | Total debt |
|---|---|
| FY2021, ended Dec 31, 2021 | — |
| FY2022, ended Dec 31, 2022 | $4.65B |
| FY2023, ended Dec 31, 2023 | $4.88B |
| FY2024, ended Dec 31, 2024 | $6.24B |
| FY2025, ended Dec 31, 2025 | $14.1B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $16.7B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 26.1% since 2021.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.192M
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2021, ended Dec 31, 2021 | 152M |
| FY2022, ended Dec 31, 2022 | 153M |
| FY2023, ended Dec 31, 2023 | 143M |
| FY2024, ended Dec 31, 2024 | 134M |
| FY2025, ended Dec 31, 2025 | 194M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 192M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.Net: $89.0M more issued than bought back
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2021, ended Dec 31, 2021 | $100M | $61.0M | — |
| FY2022, ended Dec 31, 2022 | $200M | $65.0M | — |
| FY2023, ended Dec 31, 2023 | $600M | $69.0M | — |
| FY2024, ended Dec 31, 2024 | $1.10B | $65.0M | — |
| FY2025, ended Dec 31, 2025 | $551M | $73.0M | $5.78B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | — | $89.0M | — |
Revenue (TTM)
$93.5B
+55.5% YoY
Net income (TTM)
$1.16B
−12.4% YoY
Cash
$524M
−60.2% YoY
Total debt
$16.7B
+7.4% YoY
Valuation
At current price- Market Cap
- $18.6B
- P/E
- 16.0×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.2×
- Price / Book
- 1.1×
- EV / EBITDA
- 10.3×
Growth
Trailing 12 months- Revenue (TTM)
- $93.5B
- Revenue Growth YoY
- 55.5%
- Revenue CAGR 3Y
- 1.5%
- Revenue CAGR 5Y
- —. Compound annual growth over the last 5 fiscal years
- EPS Growth YoY
- −35.0%
- Net Income Growth YoY
- −12.4%
Profitability
Trailing 12 months- Gross Margin
- 5.1%
- Operating Margin
- —
- Net Margin
- 1.2%
- FCF Margin
- −2.8%
- Return on Equity
- 7.2%
Earnings
Trailing 12 months- Net Income
- $1.16B
- EPS (diluted)
- $5.76
- EBITDA
- $3.38B
- Operating Income
- —
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $524M
- Total Debt
- $16.7B
- Net Debt
- $16.2B
- Total Assets
- $49.7B
- Total Liabilities
- $31.9B
- Shareholders' Equity
- $16.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- −$955M
- Capital Expenditure
- $1.70B
- Free Cash Flow
- −$2.66B
Dividends and risk
Last 12 months- Dividend Yield
- 2.9%
- Dividend / Share
- $2.84
- Beta (5Y)
- 0.73
Every ratio is calculated from the company’s reported figures.
Strength
Revenue grew 55.5% over the last year, to $93.5B.
Note
Net margin of 1.2% over the last 12 months.
Watch
Net debt is 4.8× EBITDA ($16.2B), a heavy load.
Watch
Free cash flow was negative (−$2.66B) over the last year.
Written by fixed rules from the reported figures, not by a person or an AI.
Latest report
Pro10-Q for the quarter ended Sep 30, 2026 · filed Oct 29, 2026
The score and findings for the newest report are part of CoreStock Pro, coming soon. Every earlier report is free.
Score of each annual report
0 to 100 · 60 means nothing notable · tap a column for its details
2025 · 10-K47Some concerns
10-K for the fiscal year ended Dec 31, 2025
Filed Feb 19, 2026 · Read the filing on EDGAR
- Bunge completed the Viterra acquisition on July 2, 2025, paying about $5.3 billion in shares and $1.9 billion in cash.
- Sales rose about 32% to roughly $70.3 billion, mostly from Viterra, but net income fell 28% to $816 million.
- Total debt more than doubled to $14.1 billion, cash fell to $1.1 billion, and operating cash flow dropped to $844 million.
- Soybean profit rose 40%, while softseed and other oilseed profit fell; a $155 million gain on a business sale helped the grain segment.
Business momentum
Mixed
“Net income attributable to Bunge shareholders was $816 million, a decrease of $321 million compared to a Net income attributable to Bunge shareholders of $1,137 million for the year ended December 31, 2024.”
Outlook
Neutral
“We intend to make capital expenditures in the range of $1.5 billion to $1.7 billion in 2026.”
Financial stress
Moderate
“resulting from our use of our revolving credit facilities, the commercial paper program, and draws on long term debt facilities to both fund the Acquisition of Viterra, as well as for current and future working capital requirements”
Tone against the previous report
About the same
Red flags
None found in this report.
Positives
Viterra deal closed, ending the uncertainty and greatly increasing the company's scale
“On July 2, 2025, we completed our previously announced Acquisition of Viterra.”
Soybean segment, the largest by sales, grew profit strongly
“Segment EBIT increased 40%, to $1,225 million for the year ended December 31, 2025.”
Large unused credit lines and a credit rating upgrade support access to funding
“At December 31, 2025, we had $9,065 million unused and available committed borrowing capacity comprising committed revolving credit facilities.”
Concerns
Debt more than doubled, pushing interest costs up by a third
“Our total debt increased by $7,813 million to $14,051 million at December 31, 2025, from $6,238 million at December 31, 2024”
Operating cash flow fell by more than half and did not cover capital spending of $1.7 billion
“Cash provided by operating activities was $844 million for the year ended December 31, 2025, compared to $1,900 million for the year ended December 31, 2024, a decrease of $1,056 million.”
Softseed profit fell despite Viterra's contribution, with other oilseeds also sharply lower
“Segment EBIT decreased 21%, to $521 million for the year ended December 31, 2025.”
New risks since the previous report
Thin value cushion on grain merchandising goodwill, which could lead to future write-downs
“with the exception of Grain Merchandising and Global Cotton, which exceeded their carrying values by approximately 9% and by approximately 15%, respectively”
Former Viterra owners hold about a third of shares and can influence the board
“or in the aggregate approximately 34% of Bunge's outstanding registered shares as of December 31, 2025”
Viterra's internal financial controls were not yet covered by the annual assessment
“We have excluded the operations of Viterra from our assessment of internal control over financial reporting as of December 31, 2025”
EU deforestation rule takes effect in late 2026, affecting soy and palm oil sales
“the EUDR, which becomes effective in December 2026 requires companies trading in certain commodities, including palm oil and soy”
Larger financing to Brazilian farmers increases exposure if they cannot repay
“we had approximately $835 million and $478 million in outstanding prepaid commodity purchase contracts, and advances to farmers”
Biggest risks named
- Viterra integration, costs and unrealized savings
- Higher debt and reliance on credit markets
- Volatile commodity and energy prices
- Weather and climate effects on crops
- Trade disputes, tariffs and government policy changes
Artificial intelligence in this business: Mentioned
How the score adds up
| Starting point | 60 | |
| Business momentum | −3 | |
| Outlook | 0 | |
| Tone against the previous report | 0 | |
| Financial stress | −8 | |
| Red flags | 0 | |
| New risks | −2 | |
| Score | 47 | |
Written by AI (Claude Opus 5.5) from the report’s text. 14 of 14 quotes were found word for word in the filing; the rest are left out. Not investment advice.
All scored reports
| Period | Report | Filed | Score | Momentum | Red flags |
|---|---|---|---|---|---|
| 10-Q | Oct 29, 2026 | Pro | |||
| 10-K | Feb 19, 2026 | 47 | Mixed | None | |
| 10-K | Feb 20, 2025 | 39 | Sharp deterioration | 1 medium | |
| 10-K | Feb 22, 2024 | 45 | Mixed | 1 medium1 minor |
How these scores work
An AI model reads the management discussion, risk factors and legal sections of each report and records what they say, quoting the filing word for word. Fixed rules then turn those findings into a score from 0 to 100, where 60 means nothing notable either way. A score describes the report, not whether the stock is a good investment, and the AI may know how things turned out later, which can colour older scores. Read the methodology
From the 10-Q for Q3 FY2026 (period ended Sep 30, 2026), filed Oct 29, 2026. View filings on SEC EDGAR